Sam Chun Dang Pharm (KOSDAQ:000250) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Mar 27
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedApr 01, 2026
DataAggregated Company Financials
Companies106
- 7D-4.4%
- 3M17.9%
- 1Y56.8%
- YTDn/a
In the last week, the Pharma industry is up 9.2%, with DongKook Pharmaceutical up 30%. During this same period, the Sam Chun Dang Pharm underperformed, falling 11%. This means that the industry has gained 80% over the past year. As for the next few years, earnings are expected to grow by 24% per annum.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 01 Apr 2026 | ₩82.7t | ₩32.2t | ₩1.6t | 15.6x | 51.1x | 2.6x |
| Fri, 27 Feb 2026 | ₩92.6t | ₩31.4t | ₩1.2t | 16.6x | 78.1x | 2.9x |
| Sun, 25 Jan 2026 | ₩74.9t | ₩31.4t | ₩1.2t | 16.1x | 63.2x | 2.4x |
| Tue, 23 Dec 2025 | ₩71.1t | ₩31.4t | ₩1.2t | 17.4x | 60x | 2.3x |
| Thu, 20 Nov 2025 | ₩67.9t | ₩31.3t | ₩1.1t | 18.3x | 64x | 2.2x |
| Sat, 18 Oct 2025 | ₩62.2t | ₩31.3t | ₩1.0t | 19.6x | 62x | 2x |
| Mon, 15 Sep 2025 | ₩62.4t | ₩31.1t | ₩925.9b | 19.9x | 67.4x | 2x |
| Wed, 13 Aug 2025 | ₩57.1t | ₩30.6t | ₩909.7b | 19.1x | 62.8x | 1.9x |
| Fri, 11 Jul 2025 | ₩56.9t | ₩30.2t | ₩914.7b | 17.4x | 62.2x | 1.9x |
| Sun, 08 Jun 2025 | ₩53.7t | ₩29.9t | ₩880.1b | 17.1x | 61x | 1.8x |
| Tue, 06 May 2025 | ₩53.5t | ₩29.6t | ₩984.4b | 17.6x | 54.3x | 1.8x |
| Thu, 03 Apr 2025 | ₩51.0t | ₩29.5t | ₩972.8b | 16.3x | 52.4x | 1.7x |
| Sat, 01 Mar 2025 | ₩55.0t | ₩29.5t | ₩1.0t | 12x | 54.8x | 1.9x |
| Mon, 27 Jan 2025 | ₩55.6t | ₩29.6t | ₩1.0t | 11.7x | 54.8x | 1.9x |
| Wed, 25 Dec 2024 | ₩53.5t | ₩29.4t | ₩989.8b | 12.2x | 54.1x | 1.8x |
| Fri, 22 Nov 2024 | ₩52.1t | ₩28.9t | ₩876.4b | 15x | 59.5x | 1.8x |
| Sun, 20 Oct 2024 | ₩63.5t | ₩28.7t | ₩833.2b | 15.8x | 76.2x | 2.2x |
| Tue, 17 Sep 2024 | ₩57.2t | ₩28.8t | ₩836.8b | 15.1x | 68.4x | 2x |
| Thu, 15 Aug 2024 | ₩54.3t | ₩28.5t | ₩768.0b | 14.8x | 70.7x | 1.9x |
| Sat, 13 Jul 2024 | ₩55.9t | ₩28.4t | ₩762.2b | 13.7x | 73.4x | 2x |
| Mon, 10 Jun 2024 | ₩54.5t | ₩30.2t | ₩910.1b | 13.4x | 59.9x | 1.8x |
| Wed, 08 May 2024 | ₩54.6t | ₩29.7t | ₩942.4b | 17.6x | 57.9x | 1.8x |
| Fri, 05 Apr 2024 | ₩52.8t | ₩29.4t | ₩922.9b | 17.5x | 57.2x | 1.8x |
| Sun, 03 Mar 2024 | ₩52.8t | ₩29.6t | ₩593.1b | 20.3x | 89.1x | 1.8x |
| Tue, 30 Jan 2024 | ₩51.8t | ₩29.6t | ₩592.3b | 22.9x | 87.4x | 1.8x |
| Thu, 28 Dec 2023 | ₩53.8t | ₩29.6t | ₩588.2b | 22.6x | 91.5x | 1.8x |
| Sat, 25 Nov 2023 | ₩49.6t | ₩29.5t | ₩622.4b | 20.5x | 79.6x | 1.7x |
| Mon, 23 Oct 2023 | ₩45.1t | ₩29.3t | ₩683.3b | 15.5x | 66x | 1.5x |
| Wed, 20 Sep 2023 | ₩52.6t | ₩29.3t | ₩683.3b | 17x | 76.9x | 1.8x |
| Fri, 18 Aug 2023 | ₩51.1t | ₩28.8t | ₩901.2b | 23x | 56.7x | 1.8x |
| Sun, 16 Jul 2023 | ₩46.8t | ₩28.8t | ₩899.2b | 21x | 52x | 1.6x |
| Tue, 13 Jun 2023 | ₩48.0t | ₩28.9t | ₩908.2b | 22.3x | 52.8x | 1.7x |
| Thu, 11 May 2023 | ₩47.9t | ₩28.5t | ₩609.3b | 21.4x | 78.6x | 1.7x |
| Sat, 08 Apr 2023 | ₩47.3t | ₩28.5t | ₩602.8b | 19.5x | 78.4x | 1.7x |
Price to Earnings Ratio
78.4x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 57.3x which is lower than its 3-year average PE of 65.6x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 39% per year over the last three years.
- Revenues for these companies have grown 4.2% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Pharma compare with similar industries?
| KR Market | -8.74% | |
| Healthcare | -3.38% | |
| Pharma | -4.38% | |
| Pharma | -4.38% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A086450 DongKook Pharmaceutical | ₩29.00k | 45.0% +₩406.0b | 92.7% | PE19.8x | |
| A128940 Hanmi Pharm | ₩555.00k | 2.6% +₩177.5b | 146.7% | PE60.4x | |
| A069620 Daewoong Pharmaceutical | ₩171.40k | 7.5% +₩138.1b | 51.3% | PE10.1x | |
| A326030 SK Biopharmaceuticals | ₩98.80k | 1.6% +₩125.3b | -0.9% | PE29x | |
| A000100 Yuhan | ₩99.90k | 1.0% +₩74.4b | -6.4% | PE38.3x |
